• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7010
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/25/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that shaft break occurred.The 70-80% stenosed target lesion was located in non-tortuous and mildly calcified left coronary artery.A 3.5mm x 12mm quantum maverick balloon catheter was advanced for dilatation; however, during the insertion the rear part of the delivery shaft was separated in two pieces.The device was removed with a snare and the procedure was completed with another of same device.There were no patient complications reported and the patient status was stable.
 
Additional Manufacturer Narrative
Returned product consisted of an incomplete quantum maverick balloon catheter.The device was visually and microscopically examined.There was blood in the manifold of the device.The full length of the device returned and the location of the hypotube separation was 86.5cm from the strain relief.The separated end of the hypotube was ovaled in shape indicating the device was kinked prior to separation.The incomplete device return was missing a portion of the hypotube, the entire shaft (guidewire lumen and inflation lumen), balloon, markerbands, and tip of the device.
 
Event or Problem Description
It was reported that shaft break occurred.The 70-80% stenosed target lesion was located in non-tortuous and mildly calcified left coronary artery.A 3.5mm x 12mm quantum maverick balloon catheter was advanced for dilatation; however, during the insertion the rear part of the delivery shaft was separated in two pieces.The device was removed with a snare and the procedure was completed with another of same device.There were no patient complications reported and the patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTUM MAVERICK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key13950525
Report Number2134265-2022-03668
Device Sequence Number6702662
Product Code LOX
UDI-Device Identifier08714729392699
UDI-Public08714729392699
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/14/2024
Device Model Number7010
Device Catalogue Number7010
Device Lot Number0027492625
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/15/2022
Supplement Date Received by Manufacturer08/03/2022
Initial Report FDA Received Date03/30/2022
Supplement Report FDA Received Date08/05/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexMale
Patient Weight70 KG
-
-